Fierce Pharma Biopharma News & Insights
网页2 天之前 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 Pharmaceutical Companies by Revenue 2021 | FiercePharma
网页2021年3月29日 · The company generated more than $11 billion in 2020, enough to rank it above other midsize pharma companies such as Regeneron, Vertex and Alexion. RELATED: And the 2021 rankings will likely bring ...
The top 20 pharma companies by 2021 revenue
网页2022年4月12日 · It was a good year to be a pharmaceutical company, especially one that came up with a product to combat COVID-19. Of the world’s top 20 pharmas ranked by 2021 revenues, 12 had at least 10% ...
The top 10 most profitable pharma companies in 2021
网页2022年6月14日 · The six largest drugmakers by 2021 revenue—J&J, Pfizer, Roche, AbbVie, Novartis and Merck & Co.—all made the top profit list but in quite a different order.
Big Pharma Companies Ranked by Revenue 2022 - Fierce Pharma
网页2023年4月18日 · The top 20 pharma companies by 2022 revenue. By Kevin Dunleavy Apr 18, 2023 12:00am. Johnson & Johnson Pfizer revenue growth Roche. For the first time in biopharma history, a company has topped ...
The top 15 best-selling cancer drugs in 2022 | Fierce Pharma
网页If there was any doubt that the oncology market is set to reach unprecedented heights, FiercePharma's top 15 list of cancer drugs in 2022 should eliminate it. All told, by 2022, the top 15 cancer ...
The top 15 blockbuster patent expirations coming this decade
网页2021年7月12日 · The biggest names set to face generic pressure in the coming years include the top four of the industry’s best-selling drugs in 2020: Humira, Keytruda, Revlimid and Eliquis. In all, nine of the ...
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
网页2018年9月28日 · The loss of Cialis comes during a major time of transformation for Lilly. During its second-quarter earnings report in July, the company announced that it will spin off its animal health unit ...
First generics to Bristol-Myers and Pfizer's Eliquis are here. But can ...
网页2019年12月26日 · As Bristol's best-selling drug before the Celgene merger—even ahead of PD-1 inhibitor Opdivo—the drug delivered $5.9 billion to the company’s top line in the first nine months of 2019.
The top 10 generic drug makers by 2021 revenue - Fierce Pharma
网页Earlier this year, the company, which is the result of a recent merger between Mylan and Pfizer’s Upjohn, sold its portfolio of biosimilars to Biocon for $3.3 billion. Two generics companies in ...
跳至内容